middle.news
Telix Powers Ahead with 63% Revenue Surge and Pipeline Milestones
8:28am on Thursday 21st of August, 2025 AEST
•
Healthcare
Read Story
Telix Powers Ahead with 63% Revenue Surge and Pipeline Milestones
8:28am on Thursday 21st of August, 2025 AEST
Key Points
63% revenue growth to $390.4 million in H1 2025
47% increase in R&D investment focused on late-stage therapeutics
Adjusted EBITDA of $21.1 million despite higher operating costs
Expansion of global manufacturing footprint through acquisitions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Telix Pharmaceuticals (ASX:TLX)
OPEN ARTICLE